In this study, a battery of oligonucleotides was directed toward the katG gene and PCR-single-stranded conformation polymorphism (SSCP) analysis was used to search for katG gene deviations in clinical isolates of Mycobacterium tuberculosis from different geographical regions. Since a complete deletion of the katG gene was not found, it is suggested that deletion is not a major mechanism of isoniazid (isonicotinic acid hydrazide; INH) resistance in these isolates. However, 7 of 39 isolates (4 of 25 from South Africa and 3 of 14 from other geographical regions) showed mobility shifts by SSCP analysis, suggesting aberrations in the katG gene. Direct sequence analysis confirmed that the mobility shifts were due to Thr-2753Ala (Thr275Ala), Arg409Ala, Arg463Leu, and Asp695Ala mutations and a 12-bp deletion in the 5 region of the katG gene. It is estimated that at least one third of the world's population is infected with Mycobacterium tuberculosis (4, 6, 7), and the current resurgence of tuberculosis complicates control of this disease. Occurrences of institutional outbreaks of tuberculosis caused by drug-resistant strains have become a further concern. In New York, N.Y., approximately 46% of tuberculosis isolates are reportedly resistant to one or more antibiotics (3, 18), with at least one strain resistant to as many as 11 drugs. Mortality rates in these outbreaks of multidrug-resistant tuberculosis can be as high as 80%, with most fatalities occurring among patients infected with human immunodeficiency virus (3, 17). There is an urgent need for a better understanding of the mechanisms of resistance to antituberculous drugs and for rapid means of detecting drug resistance in clinical isolates.
It is estimated that at least one third of the world's population is infected with Mycobacterium tuberculosis (4, 6, 7) , and the current resurgence of tuberculosis complicates control of this disease. Occurrences of institutional outbreaks of tuberculosis caused by drug-resistant strains have become a further concern. In New York, N.Y., approximately 46% of tuberculosis isolates are reportedly resistant to one or more antibiotics (3, 18) , with at least one strain resistant to as many as 11 drugs. Mortality rates in these outbreaks of multidrug-resistant tuberculosis can be as high as 80%, with most fatalities occurring among patients infected with human immunodeficiency virus (3, 17) . There is an urgent need for a better understanding of the mechanisms of resistance to antituberculous drugs and for rapid means of detecting drug resistance in clinical isolates.
Isoniazid (isonicotinic acid hydrazide; INH) has been used for treating tuberculosis since 1952, but the mechanism of its action and the development of resistance to this drug by M. tuberculosis are not fully understood. It has recently been demonstrated (by cloning studies) that the catalase-peroxidase enzyme of M. smegmatis, encoded by the katG gene, mediates susceptibility to INH (19) . Furthermore, the katG gene was deleted from some (two of eight) highly drug-resistant clinical isolates of M. tuberculosis (19) . These findings led to the hypothesis that katG deletion is associated with INH resistance. However, this mechanism is not universal, since it does not explain the resistance pattern of isolates from which the gene is not deleted.
The aim of this study was to screen clinical isolates of M. tuberculosis from different geographical regions with known resistance patterns for aberrations in the katG gene. Different regions of the gene were amplified by PCR, and the products were examined by single-stranded conformation polymorphism (SSCP) analysis. The molecular data obtained were compared with the data for reference strain H 37 Rv, the MICs of INH, and the catalase activities of appropriate isolates.
(The manuscript was submitted as part of the requirements for an M.S. degree for G. S. Pretorius.)
MATERIALS AND METHODS
Clinical isolates of M. tuberculosis. Heat-inactivated (80ЊC for 1 h) scrape cultures in sterile saline and DNAs from randomly selected clinical isolates of M. tuberculosis from South Africa (25 isolates), Switzerland (3 isolates), and the United States (11 isolates) with known resistance patterns were used in this study. The MICs of INH for the South African isolates and the reference strain H 37 Rv were determined by the agar dilution method (14). Serial twofold dilutions of INH, ranging from 0.156 to 40 g/ml and including a final concentration of 50 g/ml, were incorporated into Middlebrook 7H10 agar medium. Inoculates were prepared from 10-day-old cultures in Dubos broth, which were diluted to a concentration of approximately 2 ϫ 10 6 CFU/ml. Ten microliters of each culture was then inoculated (in duplicate) onto INH-containing and drug-free control plates, sealed in plastic bags, and incubated at 37ЊC for 21 days. The lowest concentration of INH that inhibited more than 99% of the bacterial population was considered to be the MIC. A critical INH concentration of 0.156 g/ml was used as the breakpoint to differentiate between susceptible and resistant isolates. The catalase activities of test organisms were measured by the semiquantitative method (13) . The MICs and catalase activities for isolates from other geographical regions were done by the same basic procedures (13, 14) , and the results were supplied by K. D. Eisenach. In addition to H 37 Rv, 30 clinical isolates from South Africa susceptible to INH were included as controls for mutational analysis by PCR-SSCP.
PCR procedures. A battery of oligonucleotide primers was designed (Table 1 ) from the known sequence of the katG gene (GenBank accession no. X68081) to amplify approximately 200-bp fragments at a time. PCRs were done in 100-l reaction volumes in which the final concentrations were as follows: MgCl 2 , 2.5 mM; dATP, dCTP, dGTP, and dUTP, 200 M each; 5Ј primer, 0.2 M; 3Ј primer, 0.2 M; bovine serum albumin, 0.2 g/l; and Taq polymerase (Promega), 1.5 U. Five microliters of DNA (approximately 1 g of DNA) or scrape cultures in sterile saline were used as the template for amplification. Reaction mixtures were initially heated to 93ЊC for 3 min to lyse cells, with a subsequent heating cycle of 93ЊC for 1 min, 64ЊC for 1 min, and 72ЊC for 2 min, which was repeated 30 times in a thermocycler (MedTech Multigene, Cape Town, South Africa) for all amplifications. To check that DNA was a suitable template for PCR amplification, a primer set (MT51/MT31, referred to as the diagnostic primer set) was used to amplify a 123-bp fragment of the insertion sequence IS6110 (8) in the PCR procedure. Amplified products were detected by ethidium bromide staining after electrophoresis on 12% polyacrylamide minigels (MiniProtean II; Bio-Rad).
SSCP analysis. Equal volumes of stop solution (95% formamide, 20 mM EDTA, and 0.005% [each] bromophenol blue and xylene-cyanol) and PCR amplification products (10 l each) were mixed and heat denatured at 95ЊC for 2 min. Denatured products were electrophoresed on nondenaturing 6% polyacrylamide slab gels containing 5% glycerol. Electrophoresis was performed at 50 W (constant power) in 0.6ϫ TBE buffer (10ϫ TBE ϭ 900 mM [each] Tris and boric acid and 25 mM EDTA) for 4 to 5 h with cooling from a benchtop fan (15) . FMC Gelbond film was used to facilitate the manipulation of gels. For control purposes, the PCR products of the INH-sensitive strain H 37 Rv and two fully susceptible clinical isolates were always included.
Gels were subsequently fixed for 6 min in a buffer containing 0.5% acetic acid and 10% ethanol and then placed in a 0.1% silver nitrate buffer for 10 min, after which staining was performed on a horizontal orbital shaker for 20 min or until bands were visible. The staining buffer consisted of 0.1 M NaBH 4 , 1.5 M NaOH, and 0.004% formaldehyde. Fixing was performed in a 0.75% Na 2 CO 3 buffer for 10 min.
Sequencing analysis. PCR-amplified products that showed mobility shifts (and products from other samples as specified in text) detected by PCR-SSCP were sequenced directly by the dideoxy chain termination method according to the specifications of the manufacturer (Sequenase PCR sequencing kit; U.S. Biochemicals). The samples used for sequence analysis were amplified in duplicate and sequenced with both forward and reverse primers.
RESULTS
Characteristics of resistant clinical isolates. Thirty-nine clinical isolates resistant to INH from different geographical regions were included in this study ( Table 2 ). The majority of these isolates were resistant to more than one antibiotic. The MICs of INH varied from low-level (0.2 g/ml) to high-level resistance (Ͼ50 g/ml) ( Table 2 ). Semiquantitative catalase assays were performed on all isolates, when possible, and most isolates showed low catalase activities, compared with that of reference strain H 37 Rv ( Table 2 ). South African strains 93/3, 93/16, and 93/19 required INH MICs of Ն40 g/ml with almost undetectable catalase activities, and only one strain (92/3) required an INH MIC of Ͼ40 g/ml and had a catalase activity of Ͼ60 mm. Catalase assays showed catalase activities of 60 mm for M. gordonae and M. avium-M. intracellulare, two mycobacterial species with usually high catalase activities (13) (results not shown).
katG gene deletions. Primer set RTB51/RTB31 was used to amplify a 221-bp fragment in the 5Ј region of the katG gene by PCR. An additional primer set, MT51/MT31, widely used for the detection of M. tuberculosis (8) in clinical samples was used to prove that all samples were amplifiable. Figure 1 shows sample results. All isolates were amplifiable with both sets of primers. In addition, amplification products were obtained with all of the other primer sets (Table 1 ) directed toward the katG gene for all samples. From these results, it was concluded that no complete katG gene deletion was identified in the isolates screened.
Point mutations in the katG gene. A battery of oligonucleotide primers (Table 1 ) directed against the katG gene was used to amplify different regions in this gene by PCR. Additional confirmation of the amplification of katG gene sequences was obtained by specific restriction enzyme analysis of the amplified fragments yielding expected fragments according to the known sequences, as well as Southern hybridization with a katG probe (19) (results not shown). This was followed by a search for sequence alterations in the amplified fragments by SSCP analysis. Sample results for primer sets RTB51/RTB31, RTB56/RTB36, and RTB59/RTB39 are shown in Fig. 2 . DNA fragments with altered migrations, relative to that of the control (H 37 Rv), are visible in samples 93/17 ( Fig. 2A) and TB160 (Fig. 2B) . Mobility shifts in the single-stranded bands from sample 113716 are also visible (Fig. 2C) . However, it must be noted that the amplified product in this sample was shorter than those in the other samples, possibly because of a small deletion. The same strategy was used with all of the other primer sets, and 7 of 39 samples (4 of 25 from South Africa and 3 of 14 from other geographical areas) showed either mobility shifts (indicating point mutations) or deletions of a few base pairs in the katG gene (Table 2) . Only primer sets RTB56/ RTB36 and RTB59/RTB39 detected aberrations in the katG gene in more than one isolate (isolates 93/17, 113560, and 93/21 and TB160, respectively) ( Table 2) .
Sequence analysis (Fig. 3A to E) showed that the band mobility shifts detected by SSCP analysis were due to the following mutations: CGG to CTG (isolates 93/17 and 113035) at nucleotides 1381 to 1383, GAC to GCC (isolate 93/19) at The katG sequence was recently updated in the GenBank database (accession no. X68081). When the sequence data were aligned to the updated version, it was found that the observed changes resulted in Thr-2753Ala (Thr275Ala), Arg409Ala, Arg463Leu, and Asp695Ala replacements. After careful inspection of sequences, it was concluded that the mobility shift observed by SSCP for isolate 93/20 was due to a CGC-to-GCC transition, compared with the original published sequence. The 12-bp deletion caused the replacement of the protein-coding sequence Ala-Val-Ala-Asp-Pro by a new codon for alanine.
These mutations were confirmed not only by both the forward and reverse primers from other independent PCR products but also by restriction enzyme analysis when possible. The mutations at codons 463, 695, and 275 created new restriction sites for MspI, HaeIII, and HhaI, respectively. Figure 3F shows a sample result in which the G-to-T transition in sample 93/17 caused the loss of an MspI restriction site. No additional mutations were detected when the other INH-resistant isolates were screened with MspI for this particular amplified region.
Isolate 93/3 required an exceptionally high INH MIC (Ͼ50 g/ml) and had no catalase activity. Since no katG gene deletion was found and no SSCP mobility shift was observed for this isolate, the different regions of aberrations in the katG gene (RTB51/RTB31, RTB59/RTB39, RTB57/RTB37, RTB56/ RTB36, and RTB54/RTB34) of other isolates in this study were sequenced in isolate 93/3 and no gene deviations were observed. Although it is possible to miss mutations during SSCP analysis (16), the last two findings suggest that this is not the case in this study. Thirty clinical isolates susceptible to INH were subjected to PCR-SSCP analysis as controls for those regions in which differences in the katG gene were detected. One susceptible isolate gave a band mobility shift with primer set RTB56/RTB36. It was later confirmed by sequence and restriction enzyme analyses (MspI) that this isolate has the same (G-to-T transition [codon 463]) mutation found in INH-resistant isolates 93/17 and 113560. No other band mobility shift was identified for any other region in any sample.
DISCUSSION
Limited experimental evidence has led to the hypothesis that the katG gene is associated with INH resistance in M. tuberculosis (19) . However, since no deletions of the entire katG gene were seen in the strains investigated in this study, a deletion of the whole gene must be a rare event. This is in agreement with reports (1, 9, 17) from other geographical areas where whole-gene deletion has not been reported as a frequent event. It therefore suggests that other mechanisms play an important role in INH resistance amongst clinical isolates of M. tuberculosis.
It has been speculated that point mutations are another mechanism that could be involved in the acquisition of INH resistance (17) . This hypothesis was substantiated when 7 of the 39 isolates (18%) analyzed in this study showed band mobilization shifts by PCR-SSCP analysis. Direct sequencing confirmed these data. Scattered mutations were detected but were predominantly biased toward central regions of the katG gene. Although no deletion of the complete katG gene was found in any isolate in this study, sequence data for isolate 113716 indicated that a small deletion at the 5Ј end of the gene may play a role in INH resistance in M. tuberculosis.
Apart from the initial finding that complete katG deletion may be involved in resistance to INH (19) , limited previous information about other aberrations in katG is available. In one study (17) , the analysis of katG was limited to a 282-bp segment of the 5Ј end of the gene. No DNA sequencing was done to identify point mutations, insertions, or deletions. Other studies have shown mutations in a 5Ј 237-bp fragment of katG (1) and mainly missense mutations in 23 of 36 INHresistant strains (10, 11) . Our study represents a comprehensive analysis of the katG gene in multiple clinical isolates of M. tuberculosis with a wide range of INH resistance. The functional importance of these mutations is still unknown. Attempts to predict important residues in katG of M. tuberculosis from the crystal structure of the related enzyme cytochrome-c peroxidase from yeasts have been made. A number of structurally and catalytically important residues have been predicted; in this respect, Thr-275, which was replaced in two isolates in this study, is regarded to be involved in active-site modulation and H 2 O 2 binding (12) .
Approximately equal proportions of INH-resistant isolates from South Africa (16%) and from other geographical regions (21%) showed mutations in the katG gene. Identical Arg-463 (isolates 93/17 and 113560) and Thr-275 (isolates 93/21 and TB160) mutations were seen in two separate cases when isolates from South Africa and other regions were analyzed. It has been reported that 44% of M. tuberculosis strains whose INH MICs were Ն1.0 g/ml showed the same Arg-463 mutation (5). This is suggestive of a mutational hot spot. However, one control isolate (3%; n ϭ 30), susceptible to INH, also had the Arg-463 mutation, which was also reported elsewhere (5) for a strain whose INH MIC was Յ1.0 g/ml. More isolates have to be screened to investigate the role of this mutation in INHsusceptible isolates. Concurrent with our study, a consensus sequence of katG has been published (5); it would be interesting to correlate mutational frequencies with larger numbers of samples from different geographical areas with INH resistance. A comparison was drawn between the molecular data obtained in this study and culture data. The INH MIC and semiquantitative catalase activity were relatively good indicators of resistance, except for isolate 92/3, which showed a catalase activity of Ͼ60 mm. For all of the isolates that showed katG gene aberrations, catalase activities varied from 0 to 25 mm. However, the INH MICs for these isolates ranged from lowlevel (1 g/ml) to high-level resistance (40 g/ml). This phenomenon may suggest a resistance mechanism that does not involve katG. It has been proposed that in addition to catalase involvement, other mechanisms contribute to the evolution of drug resistance in M. tuberculosis. One such alternative mechanism of resistance to INH may involve the inhA gene, recently reported to be involved in resistance (2) . It is possible that in the samples in which no katG gene defect was detected, inhA mutations are involved. Alternatively, the possibility of other resistance mechanisms, as yet undescribed, cannot be ruled out.
The PCR-SSCP technique is now widely used as a screening procedure for mutations; however, since many factors can influence the sensitivity of this procedure to detect mutations (16) , it cannot be regarded as infallible. Nevertheless, it may be an easier screening method for mutation detection than direct DNA sequencing. As the effects of mutations on the conformation of single-stranded DNA are more pronounced when the DNA fragments are small, in this study pairs of PCR primers were designed to generate fragments of approximately 200 bp. The sequence results of this study suggest that the PCR-SSCP procedure is a good indicator of mutations in PCRamplified regions. This was supported by restriction fragment length polymorphism analysis (Fig. 3F) with MspI, which showed not only that this particular Arg-463 mutation can easily be detected with this system but also that mutations were not missed during the initial PCR-SSCP screening procedure for this locus.
In conclusion, the results of this study show that alterations 
